# The Plecanatide Chronic Idiopathic Constipation (CIC) Study

> **NCT01429987** · PHASE2,PHASE3 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 951 (actual)

## Conditions studied

- Chronic Idiopathic Constipation

## Interventions

- **DRUG:** plecanatide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01429987
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 951 (ACTUAL)
- **Last updated:** 2019-05-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01429987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01429987, "The Plecanatide Chronic Idiopathic Constipation (CIC) Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01429987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*